By Craig Clough ( March 18, 2021, 10:12 PM EDT) -- AbbVie Inc. lost a bid on Thursday to have a single judge handle a pair of closely watched fraud cases over allegations that the company illegally marketed its drug Humira, with an Illinois federal judge ruling that reassignment would significantly delay a whistleblower's False Claims Act case before her....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.